Grace Colón

Grace Colón has a robust background in the biotechnology industry, serving on the Board of Directors for Voyager Therapeutics, Inc., and the Biotechnology Innovation Organization, as well as chairing the Board of Directors at Bloom Science, Inc. Inaya Therapeutics benefits from Grace Colón's leadership as CEO, Co-Founder, and Director. Academic contributions include a position on the MIT Corporation as a Board Member. Grace Colón holds a Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology and a B.S.E. in Chemical Engineering from the University of Pennsylvania.